CME Group Inc. (CME) Stock Rating Reaffirmed by Keefe, Bruyette & Woods

CME Group Inc. (NASDAQ:CME)‘s stock had its “hold” rating reissued by analysts at Keefe, Bruyette & Woods in a report issued on Thursday. They currently have a $133.00 target price on the financial services provider’s stock. Keefe, Bruyette & Woods’ target price indicates a potential downside of 0.87% from the company’s current price.

CME has been the topic of several other reports. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 18th. Royal Bank Of Canada raised their target price on CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a report on Tuesday, June 20th. Jefferies Group LLC restated a “buy” rating and set a $134.00 target price (up from $128.00) on shares of CME Group in a report on Monday, July 17th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Finally, Barclays PLC began coverage on CME Group in a report on Friday, September 8th. They set an “overweight” rating and a $139.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. CME Group has a consensus rating of “Buy” and an average price target of $133.22.

Shares of CME Group (NASDAQ:CME) opened at 134.17 on Thursday. The stock has a market cap of $45.61 billion, a P/E ratio of 27.39 and a beta of 0.72. CME Group has a 12 month low of $98.95 and a 12 month high of $134.36. The stock has a 50 day moving average price of $126.73 and a 200 day moving average price of $122.14.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The business had revenue of $925.00 million during the quarter, compared to analyst estimates of $931.05 million. During the same period last year, the company earned $1.14 earnings per share. CME Group’s quarterly revenue was up 2.1% compared to the same quarter last year. Equities analysts anticipate that CME Group will post $4.82 EPS for the current fiscal year.

WARNING: This news story was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/09/23/cme-group-inc-cme-stock-rating-reaffirmed-by-keefe-bruyette-woods-2.html.

In other news, President Bryan T. Durkin sold 9,200 shares of the firm’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total value of $1,151,196.00. Following the sale, the president now directly owns 70,938 shares of the company’s stock, valued at $8,876,471.94. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Daniel R. Glickman sold 850 shares of the firm’s stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $126.65, for a total value of $107,652.50. Following the completion of the sale, the director now directly owns 13,799 shares in the company, valued at $1,747,643.35. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,244 shares of company stock worth $6,021,890. 0.57% of the stock is currently owned by company insiders.

Large investors have recently modified their holdings of the company. BlackRock Inc. grew its position in CME Group by 2,172.6% during the first quarter. BlackRock Inc. now owns 27,265,611 shares of the financial services provider’s stock worth $3,239,152,000 after buying an additional 26,065,883 shares in the last quarter. Vanguard Group Inc. grew its position in CME Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 22,795,894 shares of the financial services provider’s stock worth $2,854,958,000 after buying an additional 563,460 shares in the last quarter. Capital International Investors grew its position in CME Group by 3.3% during the second quarter. Capital International Investors now owns 11,209,987 shares of the financial services provider’s stock worth $1,403,939,000 after buying an additional 359,845 shares in the last quarter. Edgewood Management LLC grew its position in CME Group by 26.4% during the first quarter. Edgewood Management LLC now owns 7,228,349 shares of the financial services provider’s stock worth $858,728,000 after buying an additional 1,511,753 shares in the last quarter. Finally, Janus Henderson Group PLC grew its position in CME Group by 13,530.7% during the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock worth $770,227,000 after buying an additional 6,104,897 shares in the last quarter. 82.64% of the stock is currently owned by institutional investors.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply